PHARMACOKINETICS OF HIGH-DOSE METOCLOPRAMIDE IN CANCER-PATIENTS

被引:24
作者
MCGOVERN, EM
GREVEL, J
BRYSON, SM
机构
[1] STOBHILL GEN HOSP,CLIN PHARMACOKINET LAB,GLASGOW G21 3UW,SCOTLAND
[2] STOBHILL GEN HOSP,DEPT PHARM,GLASGOW G21 3UW,SCOTLAND
[3] UNIV GLASGOW,STOBHILL GEN HOSP,DEPT MAT MED,GLASGOW G21 3UW,SCOTLAND
关键词
D O I
10.2165/00003088-198611060-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:415 / 424
页数:10
相关论文
共 35 条
[1]   EMESIS DUE TO CANCER-CHEMOTHERAPY - RESULTS OF A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL OF VARYING DOSES OF METOCLOPRAMIDE IN THE MANAGEMENT OF CIS-PLATINUM-INDUCED VOMITING [J].
ALLAN, SG ;
CORNBLEET, MA ;
LOCKHART, SP ;
WARRINGTON, PS ;
LEONARD, RCF ;
SMYTH, JF .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (12) :1481-1484
[2]   METOCLOPRAMIDE - DOSE-RELATED TOXICITY AND PRELIMINARY ANTIEMETIC STUDIES IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY [J].
ALLEN, JC ;
GRALLA, R ;
REILLY, L ;
KELLICK, M ;
YOUNG, C .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) :1136-1141
[3]  
ARNOLD DJ, 1980, P AM ASSOC CANC RES, V21, P344
[4]   DYSTONIC REACTIONS AND THE PHARMACOKINETICS OF METOCLOPRAMIDE IN CHILDREN [J].
BATEMAN, DN ;
CRAFT, AW ;
NICHOLSON, E ;
PEARSON, ADJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (05) :557-559
[5]   THE PHARMACOKINETICS OF SINGLE DOSES OF METOCLOPRAMIDE IN RENAL-FAILURE [J].
BATEMAN, DN ;
GOKAL, R ;
DODD, TRP ;
BLAIN, PG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (06) :437-441
[6]   PHARMACOKINETIC AND CONCENTRATION-EFFECT STUDIES WITH INTRAVENOUS METOCLOPRAMIDE [J].
BATEMAN, DN ;
KAHN, C ;
MASHITER, K ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (05) :401-407
[7]   CLINICAL PHARMACOKINETICS OF METOCLOPRAMIDE [J].
BATEMAN, DN .
CLINICAL PHARMACOKINETICS, 1983, 8 (06) :523-529
[8]   THE PHARMACOKINETICS OF METOCLOPRAMIDE IN MAN WITH OBSERVATIONS IN THE DOG [J].
BATEMAN, DN ;
KAHN, C ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (04) :371-377
[9]  
BELT RJ, 1981, TREATMENT CANCER CHE, P153
[10]  
BLOCK W, 1981, ARZNEIMITTEL-FORSCH, V31-1, P1041